MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2

Journal of Cellular Biochemistry

Volumn 114, Issue 12, 2013, Pages 2666-2672

  Jiping, Zeng ^a   Ming, Fang ^a,b   Lixiang, Wang ^a   Xiuming, Liang ^a   Yuqun, Shen ^a   Han, Yu ^a   Zhifang, Liu ^a   Yundong, Sun ^a   Shili, Liu ^a   Chunyan, Chen ^c   Jihui, Jia ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shandong Center for Disease Control and Prevention   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

GASTRIC CANCER; MICRORNA 212; PROLIFERATION; RBP2

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICRORNA; MICRORNA 212; RETINOBLASTOMA BINDING PROTEIN 2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; CANCER INHIBITION; CELL CYCLE ARREST; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

GASTRIC CANCER; MICRORNA-212; PROLIFERATION; RBP2;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICRORNAS; PROTEIN BINDING; RETINOBLASTOMA-BINDING PROTEIN 2; STOMACH NEOPLASMS;

EID: 84885634504     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24613     Document Type: Article

References (42)

1. Albulescu R, Neagu M, Albulescu L, Tanase C,. 2011. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers. Expert Rev Mol Diagn 11: 101-120.
2. Amiel J, de Pontual L, Henrion-Caude A,. 2012. miRNA, development, and disease. Adv Genet 80: 1-36.
3. Baer C, Claus R, Plass C,. 2013. Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res 73: 473-477.
4. Brenner H, Rothenbacher D, Arndt V,. 2009. Epidemiology of stomach cancer. Methods Mol Biol 472: 467-477.
5. Chen K, Rajewsky N,. 2007. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8: 93-103.
6. Christensen J, Agger K, Cloos PA, Pasini D, Rose S, Sennels L, Rappsilber J, Hansen KH, Salcini AE, Helin K,. 2007. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 128: 1063-1076.
7. Esquela-Kerscher A, Slack FJ,. 2006. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
8. Farazi TA, Hoell JI, Morozov P, Tuschl T,. 2013. MicroRNAs in human cancer. Adv Exp Med Biol 774: 1-20.
9. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
10. Ge W, Shi L, Zhou Y, Liu Y, Ma GE, Jiang Y, Xu Y, Zhang X, Feng H,. 2011. Inhibition of osteogenic differentiation of human adipose-derived stromal cells by retinoblastoma binding protein 2 repression of RUNX2-activated transcription. Stem Cells 29: 1112-1125.
11. Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA,. 2012. Epigenetic mechanisms in gastric cancer. Epigenomics 4: 279-294.
12. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, Hadzopoulou-Cladaras M, Iliopoulos D,. 2011. An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147: 1233-1247.
13. Hinton A, Hunter S, Reyes G, Fogel GB, King CC,. 2012. From pluripotency to islets: miRNAs as critical regulators of human cellular differentiation. Adv Genet 79: 1-34.
14. Ishteiwy RA, Ward TM, Dykxhoorn DM, Burnstein KL,. 2012. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells. PLoS ONE 7: e52106.
15. Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, Tempst P, Gilliland DG, Zhang Y, Kaelin WG, Jr., 2007. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128: 889-900.
16. Lee D, Shin C,. 2012. MicroRNA-target interactions: New insights from genome-wide approaches. Ann N Y Acad Sci 1271: 118-128.
17. Lee YC, Tzeng WF, Chiou TJ, Chu ST,. 2012. MicroRNA-138 suppresses neutrophil gelatinase-associated lipocalin expression and inhibits tumorigenicity. PLoS ONE 7: e52979.
18. Leonardo TR, Schultheisz HL, Loring JF, Laurent LC,. 2012. The functions of microRNAs in pluripotency and reprogramming. Nat Cell Biol 14: 1114-1121.
19. Li P, Jiao J, Gao G, Prabhakar BS,. 2012a. Control of mitochondrial activity by miRNAs. J Cell Biochem 113: 1104-1110.
20. Li Y, Zhang D, Chen C, Ruan Z, Li Y, Huang Y,. 2012b. MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. Mol Biol Cell 23: 1423-1434.
21. Link A, Kupcinskas J, Wex T, Malfertheiner P,. 2012. Macro-role of microRNA in gastric cancer. Dig Dis 30: 255-267.
22. Lopez-Bigas N, Kisiel TA, Dewaal DC, Holmes KB, Volkert TL, Gupta S, Love J, Murray HL, Young RA, Benevolenskaya EV,. 2008. Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation. Mol Cell 31: 520-530.
23. Okuda H, Xing F, Pandey PR, Sharma S, Watabe M, Pai SK, Mo YY, Iiizumi-Gairani M, Hirota S, Liu Y, Wu K, Pochampally R, Watabe K,. 2013. miR-7 Suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res 73: 1434-1444.
24. Pan SJ, Zhan SK, Pei BG, Sun QF, Bian LG, Sun BM,. 2012. MicroRNA-149 inhibits proliferation and invasion of glioma cells via blockade of AKT1 signaling. Int J Immunopathol Pharmacol 25: 871-881.
25. Park JK, Henry JC, Jiang J, Esau C, Gusev Y, Lerner MR, Postier RG, Brackett DJ, Schmittgen TD,. 2011. miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun 406: 518-523.
26. Petra Hudler. 2012. Genetic aspects of gastric cancer instability. Scientific World Journal 2012: 761909-761918.
27. Png KJ, Halberg N, Yoshida M, Tavazoie SF,. 2011. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481: 190-194.
28. Redis RS, Berindan-Neagoe I, Pop VI, Calin GA,. 2012. Non-coding RNAs as theranostics in human cancers. J Cell Biochem 113: 1451-1459.
29. Rossi S, Di Narzo AF, Mestdagh P, Jacobs B, Bosman FT, Gustavsson B, Majoie B, Roth A, Vandesompele J, Rigoutsos I, Delorenzi M, Tejpar S,. 2012. microRNAs in colon cancer: A roadmap for discovery. FEBS Lett 586: 3000-3007.
30. Song JH, SJ M,. 2012. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology 143: 35-47.
31. Stratmann A, Haendler B,. 2011. The histone demethylase JARID1A regulates progesterone receptor expression. FEBS J 278: 1458-1469.
32. Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL, Leung ML, El-Naggar A, Creighton CJ, Suraokar MB, Wistuba I, Flores ER,. 2010. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467: 986-990.
33. Thorns C, Kuba J, Bernard V, Senft A, Szymczak S, Feller AC, Bernd HW,. 2012. Deregulation of a distinct set of microRNAs is associated with transformation of gastritis into MALT lymphoma. Virchows Arch 460: 371-377.
34. Turrini E, Haenisch S, Laechelt S, Diewock T, Bruhn O, Cascorbi I,. 2012. MicroRNA profiling in K-562 cells under imatinib treatment: Influence of miR-212 and miR-328 on ABCG2 expression. Pharmacogenet Genomics 22: 198-205.
35. Wang Z, Qi Y, Chen Q, Yang D, Tang S, Jin X, Gao J, Fu J, Zhou Z, Wang J, Xiao X,. 2009. Cyclin A is essential for the p53-modulated inhibition from benzo(a)pyrene toxicity in A549 cells. Toxicology 256: 1-6.
36. Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, JJ S,. 2010. MicroRNA dysregulation in gastric cancer: A new player enters the game. Oncogene 29: 5761-5771.
37. Xia J, Wu Z, Yu C, He W, Zheng H, He Y, Jian W, Chen L, Zhang L, Li W,. 2012. miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1. J Pathol 227: 470-480.
38. Xu L, Wang F, Xu XF, Mo WH, Xia YJ, Wan R, Wang XP, Guo CY,. 2011. Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells. Med Oncol 28 Suppl 1: S189-S196.
39. Yamashita K, Sakuramoto S, Watanabe M,. 2011. Genomic and epigenetic profiles of gastric cancer: Potential diagnostic and therapeutic applications. Surg Today 41: 24-38.
40. Zabolotneva AA, Zhavoronkov A, Garazha AV, Roumiantsev SA, Buzdin AA,. 2012. Characteristic patterns of microRNA expression in human bladder cancer. Front Genet 3: 310-314.
41. Zeng J, Ge Z, Wang L, Li Q, Wang N, Björkholm M, Jia J, Xu D,. 2010. The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. Gastroenterology 138: 981-992.
42. Zheng L, Wang L, Ajani J, Xie K,. 2004. Molecular basis of gastric cancer development and progression. Gastric Cancer 7: 61-77.